Cargando…
Synthesis of novel coumarin–hydrazone hybrids as α-glucosidase inhibitors and their molecular docking studies
Diabetes mellitus is a metabolic disorder and more than 90% of diabetic patients suffer from type-2 diabetes, which is characterized by hyperglycemia. α-Glucosidase inhibition has become an appropriate approach to tackle high blood glucose levels. The current study was focused on synthesizing coumar...
Autores principales: | Tariq, Hafiza Zara, Saeed, Aamer, Ullah, Saeed, Fatima, Noor, Halim, Sobia Ahsan, Khan, Ajmal, El-Seedi, Hesham R., Ashraf, Muhammad Zaman, Latif, Muhammad, Al-Harrasi, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475976/ https://www.ncbi.nlm.nih.gov/pubmed/37670997 http://dx.doi.org/10.1039/d3ra03953f |
Ejemplares similares
-
Meldrum-Based-1H-1,2,3-Triazoles
as Antidiabetic Agents: Synthesis, In Vitro α-Glucosidase
Inhibition Activity, Molecular Docking Studies, and In Silico Approach
por: Avula, Satya Kumar, et al.
Publicado: (2023) -
Bio-Oriented Synthesis of Novel (S)-Flurbiprofen Clubbed Hydrazone Schiff’s Bases for Diabetic Management: In Vitro and In Silico Studies
por: Alam, Aftab, et al.
Publicado: (2022) -
Bio-Oriented Synthesis of Novel Polyhydroquinoline
Derivatives as α-Glucosidase Inhibitor for Management
of Diabetes
por: Talab, Faiz, et al.
Publicado: (2023) -
Synthesis of novel coumarin-based thiosemicarbazones and their implications in diabetic management via in-vitro and in-silico approaches
por: Zahra, Syeda Bakhtawar, et al.
Publicado: (2023) -
Novel 5-(Arylideneamino)-1H-Benzo[d]imidazole-2-thiols as
Potent Anti-Diabetic
Agents: Synthesis, In Vitro α-Glucosidase Inhibition,
and Molecular Docking Studies
por: Ali, Sardar, et al.
Publicado: (2022)